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a  b  s  t  r  a  c  t
The  biological  function  of the  pleiotropic  cytokine  interleukin-10  (IL-10),  which  has  an  essential  role  in
inﬂammatory  processes,  is  known  to be affected  by glycosaminoglycans  (GAGs).  GAGs  are  essential  con-
stituents  of the  extracellular  matrix  with  an  important  role in  modulating  the  biological  function  of many
proteins.  The  molecular  mechanisms  governing  the  IL-10–GAG  interaction,  though,  are  unclear  so  far.  In
particular,  detailed  knowledge  about  GAG  binding  sites  and  recognition  mode  on IL-10  is  lacking,  despite
of  its imminent  importance  for understanding  the  functional  consequences  of  IL-10–GAG interaction.  In
the present  work,  we  report  a  GAG  binding  site  on IL-10  identiﬁed  by  applying  computational  methods
based  on  Coulomb  potential  calculations  and  specialized  molecular  dynamics  simulations.  The  identi-
ﬁed  GAG  binding  site is  constituted  of  several  positively  charged  residues,  which  are  conserved  among
species.  Exhaustive  conformational  space  sampling  of a series  of GAG  ligands  binding  to  IL-10  led to  the
observation  of  two GAG  binding  modes  in the  predicted  binding  site,  and to  the  identiﬁcation  of IL-10
residues  R104,  R106,  R107,  and  K119  as  being  most  important  for molecular  GAG  recognition.  In silico
mutation  as well  as  single-residue  energy  decomposition  and detailed  analysis  of hydrogen-bonding
behavior  led  to  the  conclusion  that  R107  is most  essential  and  assumes  a unique  role in IL-10–GAG  inter-
action.  This  structural  and  dynamic  characterization  of  GAG-binding  to IL-10 represents  an  important
step  for  further  understanding  the  modulation  of the biological  function  of  IL-10.
ublis©  2015  The  Authors.  P
. Introduction
Interleukin-10 (IL-10) is an immunoregulatory cytokine whose
iological relevance has been extensively reviewed [1]. Its most
rominent function is to limit and eventually terminate inﬂam-
atory responses via its ability to inhibit effector functions of T
ells, monocytes, and macrophages, and by inhibiting the synthesis
f inﬂammatory cytokines such as IFN- and TNF-  ˛ [2–4]. Mal-
unction of IL-10 leads to improperly regulated immune reactions:
L-10-deﬁcient mice spontaneously develop acute and chronic
nﬂammation [5]. On the macroscopic scale, IL-10 has a crucial
mpact on tissue repair [6]. Despite the observed anti-inﬂammatory
ffects of IL-10, the attempts to use it directly as a therapeutic agent
n various inﬂammatory conditions yielded disappointing results
7]. The IL-10 system turned out to be more complex than initially
ssumed, and it was found that its functions largely depend on its
tructural micro-environment [8], and the speciﬁc immune envi-
onment in which it is released [9]. Furthermore, it was  found that
L-10 also has pro-inﬂammatory effects in certain conditions [10],
∗ Corresponding author.
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pointing towards an incredibly multifaceted role of IL-10 in biology.
Likewise, IL-10 is often called a pleiotropic cytokine.
IL-10 has been shown to bind glycosaminoglycans (GAGs)
[11,12]. GAGs are essential building blocks of the extracellular
matrix (ECM) and can be characterized as unbranched, negatively
charged polysaccharides composed of repeating disaccharide units
[13]. Based on the conﬁguration of these disaccharide building
blocks, GAGs are grouped into ﬁve classes: hyaluronan, chon-
droitin sulfate, dermatan sulfate, keratan sulfate, and heparan
sulfate/heparin. GAGs play a critical role in many biological pro-
cesses. Their multifarious biological activity arises from their ability
to interact with and directly affect the biological activity of many
cytokines, chemokines and growth factors [14–18]. Salek-Ardakani
et al. demonstrated that GAGs may  modulate IL-10 function by
showing that soluble GAGs inhibit the IL-10-induced expression
of CD16 as well as CD64 on monocytes and macrophages, revea-
ling a dependency of the inhibition strength on the GAG sulfation
degree. Interestingly, they also showed that sulfated cell surface-
bound GAGs were required for IL-10 to trigger its biological function
towards corresponding cells [11]. A recent NMR  study showed
that GAG sulfation is prerequisite for binding to IL-10: heparin
was found to be the strongest binder, and the binding afﬁnity
of different GAG types decreased with the sulfation degree. No
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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is switched off, and the second stage of the DMD  run is performed,
which is an unrestrained (“free”) molecular dynamics simulation
for relaxing the system and for collecting data. A DMD  study con-
sists of a large number of DMD  run repetitions (see Section 3 for the
Fig. 1. Schematic representation of a DMD study. A DMD study is comprised of N
DMD  runs, performed in independent simulations. Each run begins with a pulling
process: starting from a distal position, the GAG molecule is pulled towards IL-10
(shown in gray surface representation). During this process, the GAG translates and
rotates along a random path and samples its conformational space. The pulling pro-8 J.-P. Gehrcke, M.T. Pisabarro / Journal of Mo
inding was detected for hyaluronan [12]. In essence, the molec-
lar mechanisms of these effects are unclear so far. Thus, insights
nto the structural principles underlying the interaction between
L-10 and GAGs are required for understanding the biological role
f IL-10–GAG interaction.
Here, we report the identiﬁcation of a GAG binding site on IL-
0 and the detailed characterization of the molecular interaction
etween IL-10 and GAGs in this site based on simulation methods.
he calculation and analysis of the Coulomb potential of IL-10 in
olution allowed us to locate a GAG binding region on its surface.
e then employed Dynamic Molecular Docking (DMD), a recently
ublished specialized method based on molecular dynamics (MD)
imulations [20], to investigate the IL-10–GAG interaction in fur-
her detail. With DMD  we  performed exhaustive conformational
pace sampling while GAG and protein were treated as entirely
exible, and solvent was taken into account explicitly. The DMD  cal-
ulations yielded two putative GAG binding pose models as well as
nsemble-derived single-residue energetics and hydrogen bonding
ata. These data allowed the identiﬁcation of those IL-10 residues
eing most important for binding GAGs. Our results shed light
n possible molecular mechanisms governing GAG-mediated IL-10
unction modulation.
. Materials and methods
.1. IL-10 and GAG structures
The analysis described in the present work was  based on the
-ray structure of human IL-10 with PDB ID 2ILK (1.6 A˚ resolu-
ion) [20]. The biologically active unit of IL-10 is known to be a
omodimer comprised of two intercalated IL-10 monomers and
haracterized by a twofold rotational symmetry [21,22]. We have
uilt this homodimer by extending the monomeric 2ILK structure
ith a copy of itself, rotated by 180◦ around the crystallographic
wofold axis as deﬁned in the PDB entry.
The GAG molecules heparin (HP) dp4, HP dp6, hyaluronan
HA) dp4, HA dp6, chondroitin-4-sulfate (CS4) dp6, chondroitin-
-sulfate (CS6) dp6 (“dp” denoting the degree of polymerization;
.e. the number of sugar rings per molecule) were built with LEAP
23] and parameterized using GLYCAM 06 [24] as described pre-
iously [20]. MD  snapshots of these molecules are depicted in SI
ig. S1.
.2. IL-10 Coulomb potential simulation
The electrostatic potential of IL-10 was calculated with
 ﬁnite-difference numerical solver applied to the linearized
oisson–Boltzmann (PB) equation, using the PBSA program shipped
ith AmberTools 13 [23]. In the PB model applied here, IL-10 is
epresented as a dielectric body with vacuum permittivity whose
hape is deﬁned by atomic coordinates and radii. The solvent is
reated as a continuum with a relative permittivity of 80. The net
lectrostatic potential of IL-10 was calculated as the sum of its
acuum Coulomb potential and the corresponding solvent reac-
ion ﬁeld, using PBSA default parameters and a ﬁnite element grid
pacing of 1 A˚. IL-10 atomic coordinates were taken from the IL-
0 dimer structure described above. The atomic radii and point
harges of the protein were parameterized according to the FF99SB
olecular mechanics force ﬁeld [23]. Source code modiﬁcation of
he PBSA software was required for writing the discretized scalar
ata in compliance with the OpenDX data format and in units of
cal/(mol e) (whereas 1 kcal/(mol e) ∧=4.18 kJ/(mol e) for appropri-
te post-processing in VMD  [25]. Corresponding software patches
ere contributed back to the AmberTools project (see SI for further
nformation about these modiﬁcations). Graphics and Modelling 62 (2015) 97–104
2.3. Dynamic Molecular Docking of GAGs to IL-10 and data
analysis
The interaction between IL-10 and GAG molecules was investi-
gated via Dynamic Molecular Docking (DMD), a recently published
targeted molecular dynamics (tMD)-based docking method espe-
cially accounting for the effects of receptor ﬂexibility and system
solvation [20]. The DMD  principle is schematically visualized in
Fig. 1. Its cornerstone is the creation of an ensemble of MD trajecto-
ries by repetitively pulling a ligand molecule towards a predeﬁned
binding region on a receptor protein. Subsequent analysis of the
trajectory data and the ensemble of ligand poses provides atomic
information about the ligand–receptor interaction.
The geometrical DMD  parameterization requires deﬁnition of
a so-called core atom, an atom in the protein core with as little
mobility relative to the bulk of the protein as possible, as well as a
focus point near the protein surface at the center of the anticipated
binding region. The straight line connecting focus point and core
atom determines the directionality of the relative ligand–receptor
movement when the ligand is being pulled towards the receptor.
The distance between core atom and focus point corresponds to the
so-called target distance. For a more complete deﬁnition of these
terms see SI Fig. S2 and the previously published DMD  methodology
[20].
In the ﬁrst stage of a so-called DMD  run, the ligand molecule
is slowly pulled towards the receptor molecule, starting from a
distal position, as schematically visualized in Fig. 1. This pulling
process is implemented with a time-dependent harmonic poten-
tial applied to the distance between the core atom and a central
ligand atom. The pulling potential competes with the canonical
molecular mechanics potentials and with the thermal ﬂuctuations
applied in the simulation. Hence, while being directed, the trajec-
tory of relative movement between receptor and ligand remains
random. When the target distance is reached, the pulling potentialcess stops when the GAG is in proximity to the surface of IL-10 and is followed by a
long unrestrained MD  simulation. This results in an ensemble of MD trajectories as
well as in a collection of GAG poses in contact to the receptor surface, as schemati-
cally indicated here in purple, blue, orange. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web  version of this article.)
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xact numbers applied in our studies), independently performed
ith different random seeds, yielding an ensemble of MD trajecto-
ies and ligand docking poses.
The geometrical DMD  parameterization (i.e. the selection of core
tom and focus point as introduced above) used for the work pre-
ented here was based on the observations made in the Coulomb
otential analysis (cf. Section 3). Correspondingly, the DMD  focus
oint was centered on the region comprised of residues R102, R104,
106, and R107, as visualized in SI Fig. S2. The C-alpha atom of IL-
0 residue M154 was selected as the core atom. This choice was
ainly driven by the goal to maximize the target distance, because
 large target distance leads to a wide spatial distribution of ligand
olecules (among the runs within a DMD  study) around the focus
oint, and therefore allows for exhaustive Cartesian space sampling.
ocus point and core atom selection as speciﬁed above led to a target
istance of 20.5 A˚, causing DMD  to sample a signiﬁcant fraction of
he surface of IL-10 (see SI Fig. S2). This geometrical parameteriza-
ion complies with the guidelines formulated in the original DMD
ethod description [20].
Independent DMD  studies were performed for each of the six
ifferent GAG molecules listed in Section 2.1. Molecular dynam-
cs system parameterization, minimization, heat-up, equilibration
nd production protocols were chosen as described earlier [20]. The
MD simulation time and the duration of the free MD  stage were
hosen to last 3 ns and 10 ns, respectively. Summed over all DMD
tudies performed for the presented work, about 30 s of raw MD
rajectory data were created and analyzed. The simulations were
erformed on a cluster of graphics processing units using Amber’s
memd.cuda [26]. End-point free energy calculations were per-
ormed using the MMPBSA.py framework [27] as described earlier
20]. In summary, the MMPBSA method was used for obtaining a
ree energy of binding estimate G for each docking pose, and the
MGBSA method was used for obtaining a single-residue energy
ecomposition (SRED) thereof.
Crucial component of the DMD  method is the analysis of the
nsemble of MD  trajectories created in a single DMD  study, yield-
ng converged ensemble properties with statistical signiﬁcance.
ere, ensemble-derived single-residue energy decomposition was
btained as described previously [20]. Additionally, we  imple-
ented an approach for ensemble-derived hydrogen bonding
nalysis: for each free MD  trajectory within a DMD  study, the occu-
ancy of single donor and acceptor atoms was tracked over time,
nabling to ﬁlter those IL-10 residues being most involved in IL-
0–GAG hydrogen bonding. Hydrogen bond detection was  based
n atom type, distance, and angle criteria as implemented in the
D trajectory analysis software CPPTRAJ [28].
The spatial clustering method applied here for identiﬁcation
f the most frequently occurring GAG binding poses was based
n the DBSCAN algorithm [29]. It involved a custom similarity
etric optimized for GAG molecules, and was wrapped within a
ustom clustering parameter optimization procedure for ensuring
eproducibility and comparability, as outlined previously [20]. In
articular, clustering was performed with the boundary condition
hat the minimal number of clusters to be found is 1, and that the
inimal number of members within each cluster is 5.
. Results
.1. IL-10 Coulomb potential analysis
Based on the rational that Coulomb interaction plays a dom-
nant role in protein–GAG interaction, we conducted a Coulomb
otential analysis for examining the existence of putative GAG
inding regions on IL-10. A numerical Coulomb potential simula-
ion was performed for the IL-10 structure in solution, yielding the Graphics and Modelling 62 (2015) 97–104 99
spatial distribution of its electrostatic potential in terms of discrete
values on a three-dimensional grid. Based on this data, our goal
was to identify the main characteristics of the Coulomb potential
– not only on the molecular surface of IL-10, but within the entire
protein-surrounding volume. To that end, topology and strength of
the potential were analyzed with an isosurface visualization while
varying the isovalue. Fig. 2 shows the Coulomb potential isosurface
of IL-10 for four different positive isovalues ˚.
Considering the lowest isovalue shown (Fig. 2a), the volume sur-
rounding IL-10 can be categorized into different regions: large parts
of the molecular surface of IL-10 are not covered by the potential
isosurface meaning that they do not exhibit signiﬁcant electrostatic
attraction for GAGs. One noticeable region remains in which the
electrostatic potential isosurface is assembled symmetrically, fol-
lowing the twofold rotational symmetry of the IL-10 dimer. When
increasing the isovalue (Fig. 2, panels b–d), the Coulomb poten-
tial isosurface protrudes less and less into space and splits into
two regimes, narrowing down the spatial origins of the attraction
of IL-10 for negatively charged molecules: Fig. 2d shows two dis-
tinct isosurface patches close to the molecular surface of IL-10. A
closer look at the IL-10 structure reveals that the basic residues
responsible for creating these two  core regions are arginines 102,
104, 106, 107, as well as lysine 119, as depicted in Fig. 2d. Fig-
ure panel d shows a special case where the isovalue is chosen so
that the Coulomb potential isosurface does almost not reach into
space further than the molecular surface. In that case, the isovalue
itself characterizes the system by providing an estimation about the
strength of the electrostatic interaction between GAG  and IL-10 in
the bound state. For IL-10, this characteristic isovalue has a mag-
nitude of about 2 kcal/(mol e). Taken literally, this value implicates
a Coulomb energy per test charge that is about three times larger
than the thermal energy at 300 K. Hence, the identiﬁed region (the
blue part in Fig. 2d) can be assumed to possibly play a major role in
IL-10–GAG interaction, and was  treated as putative binding region
for the following DMD  analysis.
3.2. Dynamic Molecular Docking of GAGs to IL-10
The molecular interaction between GAGs and IL-10 within the
identiﬁed binding region was characterized via DMD, with the goal
to obtain important insights about the dynamics, energetics, and
atomic details of this interaction. About 30 s of MD trajectory data
were created and analyzed in the course of performing DMD.
3.2.1. Hydrogen bonding analysis
One of the goals was to identify those IL-10 residues that are
important for the establishment of hydrogen bonds to GAGs. To that
end, ensemble-derived hydrogen bond information was extracted
from a DMD  study with IL-10 and HP dp6. For each DMD  run in this
study, the occupancy of single hydrogen bond donor atoms in IL-10
with GAG acceptor atoms was  time-averaged over the last nanosec-
ond of the free MD  stage, yielding an average occupancy value per
donor atom and DMD  run. Subsequently, atoms were grouped by
residues (for instance, an arginine can theoretically donate up to
four hydrogens at the same time, and its maximum possible aver-
age occupancy therefore is 4). For each protein residue, the average
occupancy was  then normalized over all DMD  runs (N = 300), pro-
viding the mean occupancy by which the residues were ranked
thereafter. Fig. 3 shows the top four donating residues, including
box plot representations of the occupancy distribution over single
DMD  runs.
R107 is ranked ﬁrst by mean as well as median, with a measured
mean occupancy of about 1.7. That is, throughout all DMD  runs in
the study this residue donated on average almost two  hydrogen
atoms to GAG acceptor atoms, simultaneously. This can be inter-
preted as a strong indicator for the relevance of R107 in IL-10–GAG
100 J.-P. Gehrcke, M.T. Pisabarro / Journal of Molecular Graphics and Modelling 62 (2015) 97–104
Fig. 2. Isosurface representation of the Coulomb potential of IL-10 (blue) shown for multiple isovalues ˚, attractive for negative probe charges. The molecular surface of the
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anel  d. (For interpretation of the references to color in this ﬁgure legend, the read
nteraction. However, the essential observation here is that the
ccupancy distributions underlying the box plot representation of
119 and R107 have a fundamentally different shape when com-
ared to the occupancy distributions of R104 and R106, and all
ther relevant residues: the occupancy distributions of R104 and
106 have their maximum near zero and a strong decay towards
igher occupancies, yielding a median close to zero. In contrast, in
ig. 3. IL-10 key residues for GAG-interaction, as identiﬁed by ensemble-derived
ydrogen bonding information obtained from a DMD  study with IL-10 and an HP dp6
igand. The box plot representation is built from N = 300 samples per box, whereas
ach sample is the number of occupied hydrogen bond donor atoms averaged over
he data production period of one free MD  trajectory for the residue speciﬁed in
he  abscissa label. The residues are sorted by the mean (not shown), the gray bars
ndicate the median (close to zero if not visible).02, 104, 106, 107 and lysine 119 is highlighted in yellow. There,  ˚ is chosen so that
0. This visualization therefore narrows down the spatial origins of the electrostatic
 likely takes place within the symmetrically arranged regions indicated in blue in
ferred to the web version of this article.)
case of R107 and K119, the distributions have their global maxi-
mum at about 1.5 and 0.8, respectively, so that these distributions
have a median far from zero. That is, the hydrogen bonding prop-
erties of K119 and R107 qualitatively stand out compared to the
other amino acids in IL-10. The described qualitative difference
between the occupancy distribution of R107 and the other amino
acid residues can be observed in all IL-10–GAG DMD  studies we
have performed (data not shown). Hence, according to DMD  and
the resulting hydrogen bonding data, the special role of R107 is
independent of the GAG type under investigation.
3.2.2. Single-residue energy decomposition (SRED)
Ensemble-derived single-residue energy decomposition was
used as a second method for determining those IL-10 residues that
are major contributors to IL-10–GAG binding. This analysis was per-
formed on the same DMD  study as the preceding hydrogen bonding
analysis was  based on. In SRED, classical molecular mechanics
energy terms as well as solvation energy terms are extracted from
an MD trajectory and decomposed into the contribution of single
residues to the overall receptor–ligand binding energy. Within each
DMD  run, this type of data was  time-averaged. Subsequently, the
time-averaged data were merged among all DMD runs, yielding
ensemble statistics. Fig. 4 shows the four top-ranked residues that
are, according to SRED, most relevant for the interaction of IL-10
with heparin.
Considering the statistical error, the residues on ranks two
to four are not distinguishable, ranging in the interval between
−6 kcal/mol and −8 kcal/mol. R107, however, assumes a special
role, with a mean interaction energy of −13.5 ± 0.5 kcal/mol (note
that the absolute values of these energies as well as the inter-
residue energy differences are not evaluated here, we focus on
looking at the relative energy differences, which can be assumed to
J.-P. Gehrcke, M.T. Pisabarro / Journal of Molecular
Fig. 4. Top four residues in IL-10 for binding heparin, according to ensemble-merged
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Cingle-residue energy decomposition (SRED) data from a DMD  study with IL-10 and
n  HP dp6 ligand. The error bars represent the standard error of the mean obtained
rom N = 300 samples.
ield resilient information). Hence, just like the hydrogen bonding
nalysis, SRED suggests a distinguished behavior of R107 compared
o the other amino acid residues.
The ensemble-derived SRED analysis was performed for all GAG
ypes listed in Section (see SI Fig. S3). In all of these analyses, R106,
104, as well as K119 are contained within the top ﬁve residues
ontributing to binding, and R107 ranks ﬁrst.
.2.3. Impact of R107A mutation
Three independent DMD  studies with IL-10 and a HP dp4 ligand
ere performed for further characterizing the impact of arginine
07 on IL-10–GAG interaction. Two of the studies were set up
quivalently (“setup A”) except for an R107A mutation of the IL-10
equence in one of the two studies. The third study was  performed
s a control, with the wildtype IL-10 sequence and with a slightly
ifferent geometrical DMD  parameterization (“setup B”) than used
n the other two studies. Four different ensemble-averaged quan-
ities were extracted from each of the three studies. They are
resented in Table 1. Most notably, the extracted quantities are
ell-converged, with small values for their standard error of the
ean. Despite the marginal differences between setup A and B,
oth DMD  studies with the wildtype sequence yielded the same
esults, which supports the idea that DMD  is a well-reproducible
ethod and tolerant against small variations in the geometrical
etup. This is a crucial observation, meaning that signiﬁcant differ-
nces between the results of both setup A studies can be entirely
ttributed to the R107A mutation.Compared to the wildtype system, R107A mutation led to a
ecrease of about 40 % in terms of the protein–GAG binding energy
stimate G obtained from MMPBSA analysis. The decomposi-
ion of G into single energy term contributions revealed that
able 1
mpact of R107A mutation on various ensemble properties of IL-10 interacting with a HP d
nd  B differ slightly in their geometrical DMD  parameterizations. The two  setup-A-studies
nsemble averages ± the corresponding standard error of the mean, extracted from N DM
he  MMPBSA method. NHbond is the number of simultaneously established hydrogen bond
the  measured quantity is the standard deviation of a GAG–GAG root mean square distanc
oulomb energy of the protein–GAG interaction in the molecular dynamics simulations.
DMD  study 〈G〉(kcal/mol) 
IL-10 / HP dp4 (setup B, N = 200) −44.0 ± 1.1 
IL-10  / HP dp4 (setup A, N = 100) −43.5 ± 1.5 
IL-10R107A / HP dp4 (setup A, N = 100) −27.0 ± 1.1  Graphics and Modelling 62 (2015) 97–104 101
said decrease stems almost entirely from a signiﬁcant drop in the
protein–GAG Coulomb interaction energy ECoulomb. The phen-
omenological consequences of the described interaction energy
decrease in the R107A system are (i) a signiﬁcant enhancement of
the mobility of the GAG molecule relative to the protein, and (ii) a
signiﬁcant reduction of the number of simultaneously established
hydrogen bonds between protein and GAG.
SI Fig. S4 shows a comparison of the hydrogen bonding behav-
ior of the mutated and wildtype IL-10. Interestingly, the box plot
representations show similar hydrogen bonding behavior of R104,
R106, and K119 in both setup-A-studies. Particularly, the box plot
representation of the occupancy of R107 in the wildtype IL-10 ﬁnds
no resemblance in the DMD  study with the mutated protein. That
is, no other amino acid residue was  able to compensate the loss
of the polar and hydrogen bonding properties of R107. The results
presented in this section support the view in which R107 assumes
a unique role for IL-10–GAG interaction.
3.2.4. Clustering of GAG poses
The ﬁnal state of each DMD  run deﬁnes a certain GAG conforma-
tion and position relative to IL-10 which is what we  call “docking
pose”. Likewise, a DMD  study yields an ensemble of docking poses.
The spatial distribution of GAG structures within each docking pose
ensemble was grouped into clusters based on spatial similarity, for
identifying those GAG poses that occurred with highest probability
and therefore are representative. Fig. 5 shows the most populated
docking pose cluster for each of the six DMD  studies performed for
the presented work. The obtained clustering data is best interpreted
in a coarse grained fashion with a focus on identifying common as
well as divergent properties among the clusters obtained from the
different studies: it can be observed that CS4 dp6, HA dp4, HA dp6
as well as HP dp6 adopt a common cluster placement and orienta-
tion that differs from the cluster poses presented by CS6 dp6 and
HP dp4. This coarse grained interpretation results in a reduction of
the raw clustering data towards two principal GAG binding orienta-
tions: these two poses, which we  name A and B, are schematically
represented in Fig. 6. In pose A, the GAG molecule is placed in a
surface groove below residue R107. Pose B, a qualitatively different
pose, is oriented from the top left to the bottom right, with the GAG
placed above R107, and squeezed between R107 and K119. This
analysis indicates the possibility of different GAG binding poses in
the discussed binding region of IL-10. Notably, all obtained clusters
heavily involve R107 in GAG binding.
4. Discussion
We have made use of innovative computational approaches
which especially account for the dominance of long-range electro-
static interaction to investigate the molecular details of recognition
between IL-10 and a series of GAG ligands. The major reasons for
taking these computational approaches were to explore method-
ological advances for conducting in silico research on protein–GAG
systems in general, and to reveal structural details about the
so far structurally uncharacterized IL-10–GAG system. Certain
p4 ligand, as obtained from three independently performed DMD studies. Setups A
 differ only in terms of the R107A mutation. All properties shown here are time and
D  runs. G is a binding energy estimate for the protein–GAG system, obtained via
s between protein and GAG. mGAG reﬂects the GAG mobility relative to the protein
e time series, with protein–protein coordinate alignment). ECoulomb is the vacuum
〈NHbond〉 〈mGAG〉(A˚) 〈ECoulomb〉(kcal/mol)
5.8 ± 0.1 2.7 ± 0.1 −1175 ± 13
5.6 ± 0.2 2.6 ± 0.1 −1130 ± 20
4.2 ± 0.2 3.4 ± 0.3 −726 ± 21
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Fig. 5. Most populated docking pose clusters of six DMD  studies differing in GAG type and length obtained with a reproducible DBSCAN-based clustering approach. The GAG
s -10 st
i  red, a
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t
Ttructures are shown in stick representation with carbon atoms in magenta. The IL
s  colored green, R106 is shown in light green, R104 in yellow, K119 in cyan, N10 in
xperimental challenges exhibited by this macromolecular com-
lex make the use of computational approaches an alternative – and
n some cases complementary – choice to investigate the basis of
ts molecular recognition: most notably, their low binding afﬁnity
which is in the mM to M KD range [12]) severely limits the appli-
ability of traditional structure determination approaches such as
-ray crystallography and common NMR  methods.
In previous studies, we have investigated exemplary
rotein–GAG systems with the same Coulomb potential anal-
sis method as described here. We  concluded that distinct regions
f signiﬁcant electrostatic attraction are observable on the pro-
ein surface at experimentally proven GAG binding sites [20].
herefore, analysis of the strength and topology of the Coulombructure (PDB ID 2ILK) is shown in gray surface representation. The surface of R107
nd T6 in light red.
potential surrounding a protein is a simple approach for making
a well-founded theoretical prediction about those regions of the
protein on which GAG ligands most likely bind. In case of IL-10,
one such distinct region was identiﬁed (and as of the spatial
symmetry of the IL-10 dimer, this region occurs twice). Hence, the
distribution of the Coulomb potential of IL-10 in space provides
strong evidence that the interaction of IL-10 with GAGs is most
likely localized in the region comprised of residues R102, R104,
R106, and R107. It is quite important to note that already in one of
the very ﬁrst structural descriptions of IL-10, Zdanov et al. char-
acterized this region as being a special feature of IL-10, as of the
dense occurrence of basic residues [30]. Interestingly, this region is
conserved among species and unique to IL-10 as it is not observed
J.-P. Gehrcke, M.T. Pisabarro / Journal of Molecular
Fig. 6. Schematic visualization of the two principally different GAG binding modes
observed via docking ensemble clustering after performing DMD  studies with dif-
ferent GAG types. In pose A (black), the GAG is located in an IL-10 surface groove
right below R107. In pose B (magenta), the GAG is placed above R107 and within
the groove between R107 and K119. The surface of the four residues being most
important for GAG binding, according to DMD  ensemble-derived hydrogen bonding
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compelling evidence that binding of GAGs to IL-10 may  occur innalysis, is colored and labeled. (For interpretation of the references to color in this
gure legend, the reader is referred to the web version of this article.)
or other members of the IL-10 family of cytokines [31,22]. With
bout 2.0 kcal/(mol e), the characteristic isovalue of IL-10 (provid-
ng an estimate for the strength of its electrostatic potential near
ts surface in the proposed binding region) was determined to be
igniﬁcantly larger than the thermal energy at room temperature.
owever, compared to exemplary protein–GAG systems analyzed
ith the same method, IL-10 appears to exhibit a weak potential
for instance, FGF2 from PDB entry 1BFB and SDF-1 from PDB
ntry 2NWG have characteristic isovalues of 6.0 kcal/(mol e) and
.5 kcal/(mol e), respectively [20], also see SI Figures S5 and S6).
Exhaustive sampling of the dynamics of a series of IL-10–GAG
ystems via Dynamic Molecular Docking (DMD) has led to unam-
iguous data about the importance of one particular amino acid
esidue in the proposed binding region for IL-10–GAG interac-
ion: R107. Ensemble-merged properties obtained by MMGBSA
ingle-residue energy decomposition as well as hydrogen bond-
ng analysis yielded well-converged numbers and strongly suggest
hat R107 behaves qualitatively different from and outweighs the
emaining residues in the mentioned region. This observation is
upported by all performed DMD  studies. In silico analysis of the
mpact of R107A mutation corroborates this view by illustrating
hat R107 assumes a unique role in IL-10–GAG interaction, in the
ense that no other residue is able to compensate the loss of R107.
Both of the two principal poses derived from the clustering
esults (Fig. 6) involve the groove between R107 and K119 and
herefore match the fact that SRED and hydrogen bonding anal-
sis identify K119 as being important for IL-10–GAG interaction:
forementioned groove could serve as a trap, potentially anchor-
ng a GAG from two sides simultaneously, with a positively charged
mino acid residue on both sides. That groove is just wide enough
or a GAG molecule, as can be seen in the HP dp4 panel of Fig. 5.
An important experimental observation supporting the results
resented here is that the crystallographic structure of IL-10 (PDB
D 2ILK) contains three sulfate molecules, two of which are crys-
allized in positions that overlap with the principal binding poses
dentiﬁed here (see SI Fig. S7): pose A overlaps with both sulfate Graphics and Modelling 62 (2015) 97–104 103
locations, and pose B overlaps with one of them. Furthermore, pre-
viously published NMR  experiments suggest that the IL-10–GAG
binding stoichiometry changes for GAG molecules longer than hex-
asaccharides, supporting the view in which long GAG molecules
tend to simultaneously bind to both IL-10 monomers in the IL-10
dimer, an effect known as positive cooperativity [12]. Our model
indicates that a GAG molecule bound in the groove delimited by
R107 and K119 has the appropriate orientation for being able
– when elongated – to connect the twofold symmetry-related
binding regions proposed here, which would ﬁt aforementioned
observations.
The binding region discussed in the present work is comprised
of residues which are conserved among species, which by itself
could be an indicator for a functional role of IL-10–GAG interac-
tion. Salek-Ardakani et al. have shown in in vitro experiments that
IL-10 function can in fact be modulated by the presence of hep-
arin [11]. One conceivable scenario for this to happen is that GAGs
could directly affect signal transmission by hindering the recog-
nition of IL-10 by its receptors. The crystallographic structure of
IL-10 in complex with the extracellular domain of its high afﬁnity
transmembrane receptor IL-10R1 [32] reveals that the GAG bind-
ing region we  have predicted here does not geometrically overlap
with the IL-10/IL-10R1 interface. The structure of the low afﬁnity
receptor IL-10R2 is known [33], but there is so far no experi-
mentally conﬁrmed structure of the ternary IL-10/IL-10R1/IL-10R2
complex available. Before 2012, various different models of the
ternary IL-10 signaling complex were published, based on rational
positioning along the lines of very limited experimental data, or
based on molecular modeling techniques [32,34–36,22,33]. Unfor-
tunately, these models are contradictory. Recently, the structure of
the IL-20/IL-20R1/IL-20R2 complex has been published [37], which
allowed us to obtain a simple homology-based model: alignment
of IL-20R1 (from the ternary IL-20 complex) onto IL-10R1 (from the
binary IL-10 complex) was  followed by aligning IL-10R2 (resolved
individually) onto IL-20R2, yielding a basic IL-10/IL-10R1/IL-10R2
binding model (SI Fig. S8) similar to the one published by Zdanov
and Pletnev [22,35]. Based on this model, it can not be excluded that
IL-10–GAG interaction in the predicted binding region interferes
with IL-10/IL-10R2 interaction, particularly considering the case
of long GAG polymers present in the extracellular matrix. There-
fore, one possible scenario for the biological role of IL-10–GAG
interaction which needs to be addressed in future studies is that
GAGs could directly modulate IL-10 function by modulating the IL-
10/IL-10R2 interaction. Other than that, it is often speculated that
cytokine–GAG interaction in certain cases does not directly affect
the signaling cascade, but rather may  be a mechanism for cytokine
concentration and diffusion control, for instance for retaining a type
of cytokine close to its site of secretion in the tissue, which seems
to be the case for IL-2 [38,39] and IL-5 [40]. The scenario in which
longer GAG chains impair the diffusion of IL-10 without affecting
its binding to the receptors is a valid model. In that case, interac-
tion of a polymeric GAG chain with the predicted binding region
could be an effective mechanism for hindering the diffusion of the
IL-10 molecule. This model would very well ﬁt the idea of impaired
cytokine diffusion due to cell surface-attached proteoglycans. The
identiﬁcation of a GAG binding site as presented here serves as
crucial starting point to further investigate both outlined scenarios.
5. Conclusions
In conclusion, application of innovative in silico methods yieldeda well-deﬁned region. Furthermore, the analysis presented here
reveals an outstanding role of R107 for GAG binding, and in silico
mutation of R107 to alanine suggests that its contribution to
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inding cannot be resembled by any other residue of IL-10. To
urther support this hypothesis, future experiments could test the
inding afﬁnity of different IL-10 mutants for GAGs, e.g. by means
f NMR  or calorimetry methods. Furthermore, the effect of R107A
utation on the biological activity of IL-10 could be investigated.
ur results provide important insights about the determinants of
L-10–GAG interaction and shed light on the molecular basis of the
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